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May 2014

Incidence and Migration
Universal newborn screening programs that test for
particular medical conditions at birth have made it
easier to estimate statewide incidence (number of newly
diagnosed cases in a population) of sickle cell disease
(SCD) for children born in the United States. However,
using newborn screening data to estimate prevalence (total
number of cases in a population) is imprecise because these
programs have been in place for fewer than 20 years, and
the average lifespan for individuals with SCD has increased
dramatically over that time. In addition, movement of
individuals into and out of Georgia from other states and
countries influences state prevalence rates of SCD.
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We estimated Georgia’s 1-year and 5-year incidence of
SCD using the state’s newborn screening data, identifying
828 babies born from 2004 through 2008 who had positive
screening tests for the disease. This equates to 1 out of
every 880 babies born in Georgia during the five-year study
period. Among black or African American babies, the rate
was approximately 1 in 295. SCD births occurred in over
100 of Georgia’s 159 counties during the study period (see
map).
Georgia’s SCD incidence is shown in Table 1 in comparison
to that of other states participating in the RuSH
surveillance project. State rates vary by overall population
demographics. Georgia’s SCD incidence as a proportion of
all births is the highest of these five states. Its incidence among black or African American births is second to New York’s.
Table 1. SCD Births in Five States, 2004-2008
SCD incidence among...

GA

NY

NC

CA

MI

- All births: 1 of every:

880

1,259

1,435

5,644

2,496

- Black/African American births: 1 of every:

295

260

360

452

467

SCD babies who are black or African American

97%

89%

95%

89%

96%
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While we have no data source that identifies
individuals moving into the state who have
SCD, we can estimate the percentage of
young children with SCD living in Georgia
during our five-year study period who were
born in other states or countries. These
children are included in our data if they
visited one of Georgia’s comprehensive sickle
cell centers; were admitted to an emergency
department or hospital in Georgia for SCD
complications and used an in-state address;
or had a medical visit for SCD paid by one
of Georgia’s public insurance plans from
2004-2008. By matching our confirmed and
probable cases of SCD whose birth dates
are in the study period with Georgia birth
certificates and newborn screening records
for the same time period, we developed an
estimate of in-migration.
We found that 8 percent of the confirmed SCD cases and 10 percent of the confirmed or probable SCD cases born in this
time period had no matching birth certificate or newborn screening record. This suggests that 8 to 10 percent of Georgia’s
young children with sickle cell disease moved into the state after birth.
By comparison, 10% of California’s confirmed SCD cases were not linked to newborn screening records; and North
Carolina’s newborn screening follow-up program identified 14% of confirmed cases and 16% of confirmed or probable
cases who were not born in that state. It should be noted that North Carolina’s sickle cell disease surveillance system is
considerably more robust than Georgia’s.
Table 2. Children With SCD Born 2004-2008 Without a Matching In-State
Birth Certificate or Newborn Screening Record
Confirmed SCD cases

Confirmed or probable
SCD cases

8%

10%

North Carolina

14%

16%

California

10%

Not reported

Georgia

Public health leaders, health care providers, and advocates for sickle cell patients in Georgia can benefit from
understanding incidence and patterns of migration into the state by persons with SCD. This information can help them
target outreach and treatment programs to communities with high rates of the disease and migration from high-prevalence
areas outside of Georgia.
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